Cut-Off Value of Procalcitonin in Sepsis and Septic Shock patients at Dr. Soetomo Hospital
DOI:
https://doi.org/10.24293/ijcpml.v28i2.1827Keywords:
Cut-off, procalcitonin, sepsis, septic shockAbstract
Sepsis is a state of life-threatening organ dysfunction caused by dysregulation of the body's response to infection. Organ dysfunction is marked by an increase in SOFA score ≥ 2 or qSOFA score ≥ 2. Septic shock is a subset of sepsis with fairly severe circulatory disorders that can significantly increase mortality. Although the current gold standard diagnosis method for sepsis is bacterial culture, some researchers believe PCT can help identify sepsis severity because bacterial culture requires a relatively long time. This study aims to determine the cut-off point of procalcitonin in patients with sepsis and septic shock. The data taken were secondary data from the medical records of sepsis and septic shock patients in Dr. Soetomo General Hospital from 2017 to 2019. Determination of cut-off PCT for sepsis and septic shock using Receiver Operating Characteristic (ROC) analysis curve. Most sepsis patients were young (18 - 65 years) (69%) (p = 0.331) and male (60%) (p = 0.156). The majority of the clinical sepsis patients have focal infections of the respiratory system (55.17%). Patients with respiratory tract infections who develop sepsis have an OR of 6.182, which means it is six times more likely to develop septic shock. There was a significant difference between septic and non-septic PCT levels (p = 0.000), and there was a positive correlation between PCT and sepsis. The cut-off of procalcitonin in sepsis was 0.6 ng/mL, and the cut-off of procalcitonin in septic shock was 10 ng/mL.
Downloads
References
Vijayan A, Vanimaya, Ravindran S, Saikant R, Lakshmi S, Kartik R et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017;5:51.
Vincent J, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter P et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units. Critical Care Medicine. 1998;26(11):1793-1800.
Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801.
Tambajong R, Lalenoh D, Kumaat L. Profil penderita sepsis di ICU RSUP Prof. Dr. R. D. Kandou Manadoperiode Desember 2014 – November 2015. e-CliniC. 2016;4(1).
Suwondo V, Jatmiko H, Hendrianingtyas M. Karakteristik dasar pasien sepsis yang meninggal di ICU RSUP Dr. Kariadi Semarang periode 1 Januari – 31 Desember 2014. Media Medika Muda. 2015;4(4): 1586-96.
Irwin A, Carol E. Arch Dis Child Educ Pract. 2011;96(6):228-33.
Akbulut, H. & Celik, Ilhami & í–zden, Mehmet & Dogukan, Ayhan & Bulut, Vedat. (2005). Plasma procalcitonin levels in chronic haemodialysis patients. 35. 241-244.
Christ-Crain, Mirjam & Müller, Beat. (2005). Procalcitonin in bacterial infections - Hype, hope, more or less?. Swiss medical weekly. 135. 451-60.
Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. Journal of Antimicrobial Chemotherapy. 2011;66(Supplement 2):ii33-ii40.
Khosdel A, Mahmoudzadeh M, Kheiri S, Imani R, Shahabi G, Saedi E et al. Sensitivity and specificity of procalcitonin in diagnosis of neonatal sepsis. Iran J Pathol. 2008;.
Arif SK, Wahyuddin AMF, Musba AMT, 2017. Akurasi diagnostic procalcitonin sebagai penanda serologis untuk membedakan antara sepsis bacterial dan sepsis viral. Jurnal Anestesiologi Indonesia 9(3): 157-67.
Kordek A, Giedrys-Kalemba S, Pawlus B, Podraza W, Czajka R. Umbilical Cord Blood Serum Procalcitonin Concentration in the Diagnosis of Early Neonatal Infection. Journal of Perinatology. 2003;23(2):148-153.
Lee W, Kang D, Back J, Kim H, Chung J, Shin B. Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients. The Korean Journal of Internal Medicine. 2015;30(2):198–204.
Aziz S, Nelwan E, Sukrisman L, Suhendro S. Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients. BMC Research Notes. 2018;11(1).
Aydemir C, Aydemir H, Kokturk F, Kulah C, Mungan A. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis. BMC Pediatrics. 2018;18(1).
Wu S, Liang C, Zhang Y, Hu W. Elevated serum procalcitonin level in patients with chronic kidney disease without infection: A case"control study. Journal of Clinical Laboratory Analysis. 2019;34(2).
Nasir N, Jamil B, Siddiqui S, Talat N, Khan F, Hussain R. Mortality in sepsis and its relationship with gender. Pak J Med Sci.2015;31(5):1201–6.
Wichmann M, Inthorn D, Andress H, Schildberg F. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Medicine. 2000;26(2):167-172.
George RL, McGwin G, Jr, Metzger J, Chaudry IH, Rue LW. The association between gender and mortality among trauma patients as modified by age. J Trauma. 2003;54(3):464–471. doi: 10.1097/01.TA.0000051939.95039.E6.
Frink M, Pape HC, van Griensven M, Krettek C, Chaudry IH, Hildebrand F. Influence of sex and age on mods and cytokines after multiple injuries. Shock. 2007;27(2):151–156. doi: 10.1097/01.shk.0000239767.64786.de.
Dremsizov T, Clermont G, Kellum J, Kalassian K, Fine M, Angus D. Severe Sepsis in Community-Acquired Pneumonia. Chest. 2006;129(4):968-978.
Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*. Pediatric Critical Care Medicine. 2005;6(1):2-8.
Tambo M, Okegawa T, Shishido T, Higashihara E, Nutahara K. Predictors of septic shock in obstructive acute pyelonephritis. World Journal of Urology. 2013;32(3):803-811.
Stoeckle M, Kaech C, Trampuz A, Zimmerli W. The role of diabetes mellitus in patients with bloodstream infection. Swiss Med Weekly. 2009;138(35-36):512-519.
Burhan Gunawan f. Hubungan tingkat keparahan sepsis dengan diabetes melitus terkontrol dan tidak terkontrol menggunakan parameter Hba1c di Rumah Sakit Royal Taruma Jakarta Barat periode 2015-2017. Tarumanagara Medical Journal. 2019;.
Branco R, Garcia P, Piva J, Casartelli C, Seibel V, Tasker R. Glucose level and risk of mortality in pediatric septic shock*. Pediatric Critical Care Medicine. 2005;6(4):470-472.
Esper A, Moss M, Martin G. The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Critical Care. 2009;13(1):R18.
Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Medicine. 2000;26(S1):S064-S074.
Kalra O. Approach to a patient with urosepsis. Journal of Global Infectious Diseases. 2009;1(1):57.
Lee J, Lee Y, Cho J. Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER. Journal of Infection and Chemotherapy. 2012;18(1):130-133..
Greenhalgh D. Sepsis in the burn patient: a different problem than sepsis in the general population. Burns & Trauma. 2017;5.
Fuss J, Voloboyeva A, Poliovyj V. Prognostic value of using neutrophil-lymphocyte ratio in patients with burn injury for the diagnosis of sepsis and bacteraemia. Polish Journal of Surgery. 2018;90(4):20-24.
Taylor R, Jones A, Kelly S, Simpson M, Mabey J. A Review of the Value of Procalcitonin as a Marker of Infection. Cureus. 2017;.
Muthiah K, Rachakonda K, Davis M, Simmons E, Schier G, Gil F. Prospective evaluation of procalcitonin in sepsis in the Illawarra area of Australia: PEPSIA study. Crit Care Resusc. 2007;9(2):137-142.
Sharma S, Duggal N. Role of procalcitonin, Il-6 and C- reactive protein in suspected cases of sepsis. Indian Journal of Pathology and Microbiology. 2019;62(4):578.
Ghorbani G. Procalcitonin Role in Differential Diagnosis of Infection Stages and Non Infection Inflammation. Pakistan Journal of Biological Sciences. 2009;12(4):393-396.
Liu X, Wang D, Fang Y, Ye W, Liu S, Lou N. Initial procalcitonin level predicts infection and its outcome in patients with non-Hodgkin lymphoma with febrile neutropenia. Leukemia & Lymphoma . 2015;56(1):85-91.
Jeddi R, Ghédira H, Ben Amor R, Turki A, Kacem K, Ben Abdennebi Y, Ben Lakhal R, Aissaoui L, Ben Abid H, Bel Hadjali Z, Meddeb B. Risk factors of septic shock in patients with hematologic malignancies and Pseudomonas infections. Hematology. 2011 May;16(3):160-5. doi: 10.1179/102453311X12953015767293. PMID: 21669056.
Pupelis G, Drozdova N, Mukans M, Malbrain M. Serum procalcitonin is a sensitive marker for septic shock and mortality in secondary peritonitis. Anestezjologia Intensywna Terapia. 2014;46(4):262-273.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
